dm+d
108809004
Articles
Rituximab products: information for supporting intrathecal risk assessment
11 August 2022
Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administrationLactation Safety Information
for lymphoma/CLL
for lymphoma/CLL
-
Limited published evidence of safety indicates small amounts in breast milk which are likely to be degraded in infants GI tract
Long half-life increases risk of accumulation in breastfed infants
Infants should be monitored for signs of infection and immunosuppression
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
16 August 2020
for rheumatoid arthritis
for rheumatoid arthritis
See summary
Limited published evidence of safety indicates small amounts in breast milk which are likely to be degraded in infants GI tract
Long half-life increases risk of accumulation in breastfed infant
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
16 August 2020